 EMERYVILLE, Calif., Sept. 27, 2021 PRNewswire -- Dynavax Technologies Corporation Nasdaq: DVAX, a biopharmaceutical company focused on developing and commercializing vaccines, today announced that it will participate in the following investor conferences. 